Open Tender Watch
Menu v
ACCESS EN PT
← Companies Company PT

SANOFI - PRODUTOS FARMACÊUTICOS, LDA

NIF 500134960
↓ CSV ↓ JSON
Risk Flags
A1 · Repeat Direct Award €74,895,728 138 contracts
Same supplier receives ≥2 direct awards in 36 months with cumulative value above the CCP Art. 113 §2 statutory cap
HIGH €74,895,728 138 contracts
A2 · Late Publication €17,905,217,535 5,600 contracts
Contract published to BASE more than 10 days after the signing date
LOW €17,905,217,535 5,600 contracts
A5 · Threshold Splitting €40,507,335 181 contracts
Contract value falls within 5% below a procedural threshold (€5K / €20K / €75K / €150K / €5.35M). Score: 35 · Severity: Medium.
HIGH €40,507,335 181 contracts
A6 · Low Competition €507,955,997 167 contracts
Only one bidder participated in a competitive procedure
MEDIUM €507,955,997 167 contracts
A9 · Price Overrun €73,764 7 contracts
Effective price exceeds base price by >50% (score 30) or >100% (score 55); or effective price is <50% of base (score 10, possible predatory bid or data error). Severity: Medium/High/Low.
HIGH €73,764 7 contracts
A9 · Abnormal Price Reduction €23,235,325,304 2,704 contracts
Effective price exceeds base price by >50% (score 30) or >100% (score 55); or effective price is <50% of base (score 10, possible predatory bid or data error). Severity: Medium/High/Low.
LOW €23,235,325,304 2,704 contracts
C3 · Missing Mandatory Fields €14,326,185 119 contracts
CPV code, procedure type, or base price absent for the procedure type, or base price exceeds ±€1 trillion (implausible data entry). Score: 20 · Severity: Low.
LOW €14,326,185 119 contracts

Procurement Network

Aggregated links between this entity and connected counterparties

Public view excludes person-level links and tax identifiers.

Loading network…
Legend Focus entity Public body Company Anonymized individual

Contracts by Contracting Authority

335
€1,312,432,947
65
€1,112,172,483
527
€974,909,583
332
€934,480,965
151
€925,670,211
39
€818,516,811
628
€774,629,736
58
€730,416,588
410
€704,702,952
85
€692,263,962
74
€671,905,157
62
€653,576,073
104
€635,987,675
109
€623,649,496
91
€608,544,587
52
€607,357,024
78
€559,213,855
80
€551,428,223
68
€539,506,031
120
€527,792,680
Page 1 of 4 · 78 authorities
Next →

All Contracts Won

Signal: All A1 · Repeat Direct Award A2 · Late Publication A5 · Threshold Splitting A6 · Low Competition A9 · Price Overrun A9 · Abnormal Price Reduction C3 · Missing Mandatory Fields

Page 1 of 157 · 7,813 contracts

S1/1160/2020 - Dupilumab 300mg/2 ml sol inj sc seringa
PT · 6462737 · Ajuste direto simplifi...
€0
04/01344.11/2020 - Aquisição de enoxaparina sódica 60 mg/0.6 ml sol inj ser 0.6 ml sc
PT · 6630411 · Ajuste direto simplifi...
€0
S1/2633/2020 - enoxaparina 60 mg/0,6 ml sol inj
PT · 6895509 · Ajuste direto simplifi...
€0
LMPQF ADS-Medicamentos e dispositivos_COVID19
PT · 6976676 · Ajuste direto simplifi...
€0
Aquisição de Material Farmacêutico
PT · 8374666 · Ajuste direto simplifi...
€0
Insulina glargina 100 U/ml Acção prolong Sol inj Caneta 3 ml SC
PT · 7537808 · Ajuste direto simplifi...
€0
Insulina glargina 100 U/ml Acção prolong Sol inj Fr 10 ml SC
PT · 7537811 · Ajuste direto simplifi...
€0
Insulina glargina 100 U/ml Acção prolong Sol inj Fr 10 ml SC
PT · 7598009 · Ajuste direto simplifi...
€0
Insulina glargina 100 U/ml Acção prolong Sol inj Fr 10 ml SC
PT · 7651938 · Ajuste direto simplifi...
€0
Insulina glargina 100 U/ml Acção prolong Sol inj Fr 10 ml SC
PT · 7718953 · Ajuste direto simplifi...
€0
Enoxaparina sodica 60 mg/0.6 ml Sol inj Ser 0.6 ml IV SC Extracorp
PT · 7718946 · Ajuste direto simplifi...
€0
Insulina glargina 100 U/ml Acção prolong Sol inj Fr 10 ml SC
PT · 7815215 · Ajuste direto simplifi...
€0
Enoxaparina sodica 60 mg/0.6 ml Sol inj Ser 0.6 ml IV SC Extracorp
PT · 7808782 · Ajuste direto simplifi...
€0
Aqusição de Produtos Farmacêuticos - Medicamentos Anti-Infecciosos
PT · 8374672 · Ajuste direto simplifi...
€0
Insulina glargina 100 U/ml Acção prolong Sol inj Caneta 3 ml SC
PT · 7651939 · Ajuste direto simplifi...
€0
Glatimero(acetato) inj 20mg;Enoxaparina 60mg/0,6ml;Exoxaparina 80mg/0,8ml; Leflunomida 20mg;Leflunomida 20mg;Milrinona 10mg/10ml;Nilutamida 150mg;Rasburicase 100mg/2ml;Tiapride 100mg/2ml
PT · bf1eef6b14c8b2bc372a · Ajuste direto
A2 · Late Publication
€534,141 2009-02-26
Paracetamol 1000mg sup. adulto
PT · 81f6e92a4b03c5fe519e · Ajuste direto
A2 · Late Publication
€560 2009-05-27
Etambutol Comp 400mg
PT · 20be13852f5c890837f5 · Ajuste direto
A2 · Late Publication
€2,731 2009-06-17
14.500 supositórios de paracetamol 500mg junior
PT · 0564f161b6918a592e7a · Ajuste direto
A2 · Late Publication
€870 2009-06-22
Docetaxel,20mg,fr/amp.5ml;Docetaxel,80mg,fr/amp.2ml;Lenograstim (G-CSF-GLIC),263,fr/amp
PT · 9cba5ca394f459a8f7c4 · Ajuste direto
A2 · Late Publication
€557,224 2009-07-09
Medicamentos Enoxiparina, Acetato de Glátiramero e Riluzol
PT · 3d4ef2306217abdb527c · Ajuste direto
A2 · Late Publication A1 · Repeat Direct Award
€255,685 2011-07-18
Fornecimento de Diversos Medicamentos para o ano de 2012.
PT · 450072 · Ao abrigo de acordo-qu...
A2 · Late Publication
€164,970 2012-01-05
Aquisição de Hormonas e outros medicamentos usados no tratamento de doenças endócrinas.
PT · 451563 · Ao abrigo de acordo-qu...
A2 · Late Publication
€9,906 2012-01-05
Alfuzosina 10 mg comp./Oxibutinina 5 mg comp.
PT · 496392 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€0 2012-01-11
aquisicao de medicamentos gerais durante o ano de 2012
PT · 652225 · Ajuste Direto Regime G...
A2 · Late Publication
€24,280 2012-01-13
Aquisição de Medicamentos de Consumo Geral
PT · 448604 · Ao abrigo de acordo-qu...
€0 2012-01-16
Aquisição de Etambutol, Rifampicina, Isomiazida
PT · 453741 · Ajuste Direto Regime G...
€44,196 2012-01-17
580 Tiaprina 100 mg/2ml sol. inj Fr 2ml IM IV
PT · 473824 · Ajuste Direto Regime G...
A2 · Late Publication A9 · Abnormal Price Reduction
€75,000 2012-01-19
Aquisição de Vitamina A composta em pomada
PT · 456444 · Ajuste Direto Regime G...
A2 · Late Publication
€4,050 2012-01-20
Acetilsalicilato de lisina/Clopidogrel/Enoxaparina sodica 20 mg/Enoxaparina sodica 40 mgHeparina sodica
PT · 453677 · Ajuste Direto Regime G...
A1 · Repeat Direct Award
€0 2012-01-25
Docetaxel 20 mg/Docetaxel 80 mg/Nilutamida 50 mg comp
PT · 454337 · Ajuste Direto Regime G...
A1 · Repeat Direct Award
€0 2012-01-25
Acetilsalicilato de lisina 180 mg sol. oral saq./Enoxaparina sódica 20 mg 0.2 ml sol.inj./Enoxaparina sódica 40 mg 0.4 ml sol.inj./ Heparina sódica 25 U.I. sol. inj. fr 5 ml
PT · 496579 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€0 2012-01-25
Acido ursodesoxicólico 150 mg comp
PT · 496418 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€0 2012-01-25
Rifampicina/Levofloxacina/Rifampicina/Pirazinamida/Etambutol
PT · 455356 · Ajuste Direto Regime G...
A1 · Repeat Direct Award
€0 2012-01-26
Oxido de Zinco 270 mg pom Bisn 20 g
PT · 496914 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€0 2012-02-01
Aquisição de Medicamentos do Sistema Nervoso Cerebrospinal, ao abrigo do Concurso do ACSS N,02/2010
PT · 467843 · Ao abrigo de acordo-qu...
A2 · Late Publication
€29,634 2012-02-03
Aquisição de medicamentos de Consumo Geral e outros ao abrigo do Concuro do ACSS n.18/2012
PT · 478078 · Ao abrigo de acordo-qu...
A2 · Late Publication
€22,545 2012-02-03
Levotiroxina sódica 0.1 mg comp./Glibenclamida 2.5 mg comp/Glimepirida 1 mg comp./Insulina glargina 100 U.I. accão porlong sol. inf. fr 10 ml/Insulina Isofânica 100 U.I accão interm susp inj. cart 3 ml
PT · 497190 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€0 2012-02-08
Adenosina 6 mg , 2 ml sol. inj fr. 2 ml/Pentoxifilina 100 mg , 5 ml sol. inj fr 5 ml/pentoxifilina 400 mg comp/Diltiazem 60 mg comp
PT · 497868 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€0 2012-02-15
Rifampicina 300 mg Cáps;Pirazinamida 500 mg Cáps;Etambutol 400 mg Comp e Rifampicina 20 mg/ml Susp oral Fr 60 ml.
PT · 515621 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€0 2012-03-07
Etambutol 400 mg comp
PT · 521171 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€0 2012-03-07
Aquisição de tiocolquicosido e amiodarona
PT · 497030 · Ajuste Direto Regime G...
A2 · Late Publication
€22,637 2012-03-13
Aquisição de 600 seringas de Enoxaparina sodica 40mg/0.4ml sol inj
PT · 500137 · Ajuste Direto Regime G...
A2 · Late Publication
€1,555 2012-03-28
Aquisição de medicamentos
PT · 691766 · Ajuste Direto Regime G...
A2 · Late Publication
€5,760 2012-03-28
Aquisição de Isoniazida 150mg e Rifampicina 300mg
PT · 501818 · Ajuste Direto Regime G...
A2 · Late Publication
€7,680 2012-03-30
quisição de Isoniazida 150+Rifampicina 300, Pirazinamida 500mg e Etambutol 400mg
PT · 501741 · Ajuste Direto Regime G...
A2 · Late Publication
€13,782 2012-04-02
Paracetamol 32mg/ml sol oral fr 120 ml; Riluzol 50mg comp; Tiocolcosido 4mg/2ml sol inj fr 2 ml IM; Valproato de sódio 200mg/ml sol oral Fr 50 ml; Metoclopramida 1 mg/ml sol oral fr 200 ml; Bromazepam 1.5 e 3 mg comp; Venlafaxina 75 mg comp LP;Vigabatrina 500mg comp e Litio 400 mg comp LM
PT · 511819 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€0 2012-04-27
Aquisição de Etambutol 400 mg
PT · b3cf9d9dfdfc3b4aca25 · Ao abrigo de acordo-qu...
A2 · Late Publication
€2,860 2012-05-03
Aquisição de Etambutol 400 mg
PT · 776854 · Ao abrigo de acordo-qu...
A2 · Late Publication A9 · Abnormal Price Reduction
€7,474 2012-05-03
TIOCOLQUICOSIDO - SOL INJ 2 mg / ml IM - 2 ml Acetilsalicilato de lisina - INJ 900 mg IM / IV - 5 ml PARACETAMOL - SUSP ORAL 4% (200 mg<>5 ml)
PT · 778754 · Ao abrigo de acordo-qu...
A2 · Late Publication A9 · Abnormal Price Reduction
€30,247 2012-05-03
Next →
Overview
Total Value Won
€23,580,624,795
Contracts Won
7,813
Score 270380 · CRITICAL RISK
NIF
500134960
Country
PT
Directors & Officers

Personal data is pseudonymised for public access. Authenticate with a journalist token to view full names and NIFs.

  • A.J. [P-80b1]
    Gerente
    since 2012-06-11
  • A.D. [P-b42a]
    Gerente
    since 2014-03-13
  • E.Y. [P-6b36]
    Gerente
    since 2009-07-20
  • E.Y. [P-6b36]
    Gerente
    since 2013-05-06
  • E.Y. [P-6b36]
    Gerente
    since 2017-04-21
  • F.H. [P-552f]
    Gerente
    since 2022-09-19
  • H.P. [P-8f90]
    Gerente
    since 2022-09-19
  • J.C. [P-68bf]
    Gerente
    since 2013-05-06
  • L.M. [P-2cbf]
    Gerente
    since 2017-04-21
  • M.A. [P-5a28]
    Gerente
    since 2012-03-29
  • P.H. [P-715b]
    Vogal
    since 2008-10-08
  • P.H. [P-715b]
    Gerente
    since 2009-07-20
  • P.H. [P-715b]
    Gerente
    since 2010-06-18
  • R.G. [P-82e4]
    Gerente
    since 2012-10-08
  • S.J. [P-ba88]
    Gerente
    since 2015-05-25
  • A.N. [P-619a]
    Sócio
    since 2009-07-20
  • A.N. [P-619a]
    Sócio
    since 2012-03-29
  • S.A. [P-d154]
    Sócio
    since 2012-03-29
  • S.A. [P-d154]
    Sócio
    since 2017-01-26
  • S.F. [P-48a6]
    Sócio
    since 2019-05-31
  • S.A. [P-7997]
    Sócio
    since 2012-03-29
  • S.A. [P-7997]
    Sócio
    since 2017-01-26
  • S.A. [P-7997]
    Sócio
    since 2019-05-31
  • S.A. [P-66a2]
    Sócio
    since 2009-07-20
  • S.A. [P-23ed]
    Sócio
    since 2009-07-20
  • S.A. [P-77cb]
    Sócio
    since 2009-07-20
  • A.J. [P-80b1]
    Gerente
    2013-05-06 → 2015-03-12
  • A.M. [P-e9b6]
    Gerente
    2017-04-21 → 2018-06-20
  • A.M. [P-3895]
    Administrador
    until 2008-07-24
  • C.J. [P-f846]
    Gerente
    2014-03-13 → 2014-10-14
  • F.A. [P-a314]
    Gerente
    2015-03-12 → 2015-05-25
  • F.J. [P-1a2d]
    Gerente
    2018-06-21 → 2022-09-19
  • F.H. [P-9178]
    Gerente
    2009-07-20 → 2010-07-12
  • J.R. [P-2e21]
    Gerente
    2010-06-18 → 2012-05-22
  • M.A. [P-5a28]
    Gerente
    2013-05-06 → 2013-12-12
  • M.A. [P-8a48]
    Gerente
    2017-04-21 → 2022-09-19
  • O.M. [P-f83e]
    Gerente
    2010-07-12 → 2012-10-08
  • R.G. [P-82e4]
    Gerente
    2013-05-06 → 2014-03-13
Ownership & Registries

Beneficial ownership data (shareholders, directors, ultimate beneficial owners) is not yet imported. Links below open external public registries.

Registo Comercial (MJ) ↗ RCBE — Beneficial Ownership Register ↗

Full RCBE access requires judicial authentication (CJEU 2022 ruling limits public exposure).

Search in TED (EU procurement) ↗
Phase 7 — ownership layer planned